260 related articles for article (PubMed ID: 17180589)
21. In vitro activity of moxifloxacin compared to other antimicrobials against streptococci isolated from iatrogenic oral bacteremia in Spain.
Tomás I; Alvarez M; Limeres J; Otero JL; Saavedra E; López-Meléndez C; Diz P
Oral Microbiol Immunol; 2004 Oct; 19(5):331-5. PubMed ID: 15327647
[TBL] [Abstract][Full Text] [Related]
22. Viridans streptococcus bacteremia in children on chemotherapy for cancer: an underestimated problem.
Ahmed R; Hassall T; Morland B; Gray J
Pediatr Hematol Oncol; 2003 Sep; 20(6):439-44. PubMed ID: 14631617
[TBL] [Abstract][Full Text] [Related]
23. Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand.
Reechaipichitkul W; Assawasanti K; Chaimanee P
Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):320-6. PubMed ID: 17124993
[TBL] [Abstract][Full Text] [Related]
24. Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF).
Maeda Y; Elborn JS; Parkins MD; Reihill J; Goldsmith CE; Coulter WA; Mason C; Millar BC; Dooley JS; Lowery CJ; Ennis M; Rendall JC; Moore JE
J Cyst Fibros; 2011 Mar; 10(2):133-9. PubMed ID: 21145793
[TBL] [Abstract][Full Text] [Related]
25. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients.
Collin BA; Leather HL; Wingard JR; Ramphal R
Clin Infect Dis; 2001 Oct; 33(7):947-53. PubMed ID: 11528564
[TBL] [Abstract][Full Text] [Related]
26. [Antibiotic susceptibility to microorganisms isolated in blood cultures of patients an the Ignacio Chavez National Institute of Cardiology].
Villegas O; Rivera Martínez E; López Vidal Y; Vázquez Larios R
Rev Invest Clin; 1994; 46(4):267-77. PubMed ID: 7973153
[TBL] [Abstract][Full Text] [Related]
27. Pneumococcal bacteraemia in Belgium (1994 2004): the pre-conjugate vaccine era.
Flamaing J; Verhaegen J; Vandeven J; Verbiest N; Peetermans WE
J Antimicrob Chemother; 2008 Jan; 61(1):143-9. PubMed ID: 17999974
[TBL] [Abstract][Full Text] [Related]
28. Comparison of antibiotic susceptibility in viridans group streptococci in low and high antibiotic-prescribing General Practices.
Goldsmith CE; Hara Y; Sato T; Nakajima T; Nakanishi S; Mason C; Moore JE; Matsuda M; Coulter WA
J Clin Pharm Ther; 2015 Apr; 40(2):204-7. PubMed ID: 25604860
[TBL] [Abstract][Full Text] [Related]
29. Viridans group streptococcal infections among children with cancer and the importance of emerging antibiotic resistance.
Bruckner L; Gigliotti F
Semin Pediatr Infect Dis; 2006 Jul; 17(3):153-60. PubMed ID: 16934710
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial resistance of Staphylococcus aureus and oral streptococci strains from high-risk endocarditis patients.
Groppo FC; Castro FM; Pacheco AB; Motta RH; Filho TR; Ramacciato JC; Florio FM; Meechan JG
Gen Dent; 2005; 53(6):410-3. PubMed ID: 16366048
[TBL] [Abstract][Full Text] [Related]
31. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
Laupland KB; Ross T; Gregson DB
J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
[TBL] [Abstract][Full Text] [Related]
32. Adult methicillin-resistant Staphylococcus aureus bacteremia in Taiwan: clinical significance of non-multi-resistant antibiogram and Panton-Valentine leukocidin gene.
Wang JL; Wang JT; Chen SY; Hsueh PR; Kung HC; Chen YC; Chang SC
Diagn Microbiol Infect Dis; 2007 Dec; 59(4):365-71. PubMed ID: 17878063
[TBL] [Abstract][Full Text] [Related]
33. Reduced susceptibility to penicillin of viridans group streptococci in the oral cavity of patients with haematological disease.
Westling K; Julander I; Ljungman P; Heimdahl A; Thalme A; Nord CE
Clin Microbiol Infect; 2004 Oct; 10(10):899-903. PubMed ID: 15373884
[TBL] [Abstract][Full Text] [Related]
34. Erythromycin resistance in viridans streptococci bacteremia is clinically significant.
Grey E; Mraz M; Docze A; Korcova J; Bucko E; Krcmery V
Chemotherapy; 2007; 53(1):42-3. PubMed ID: 17202810
[No Abstract] [Full Text] [Related]
35. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region.
Laupland KB; Gregson DB; Church DL; Ross T; Pitout JD
Clin Microbiol Infect; 2008 Nov; 14(11):1041-7. PubMed ID: 19040476
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial susceptibility of viridans group streptococcal blood isolates to eight antimicrobial agents.
Smith A; Jackson MS; Kennedy H
Scand J Infect Dis; 2004; 36(4):259-63. PubMed ID: 15198181
[TBL] [Abstract][Full Text] [Related]
37. [Identification and antibiotic susceptibility of viridans group streptococci isolates recovered from patients hospitalized at a teaching hospital in Buenos Aires City].
Heine AC; García S; Barberis C; Vay C; E Mollerach M; Bonofiglio L; Famiglietti Á
Rev Argent Microbiol; 2019; 51(1):26-31. PubMed ID: 29941157
[TBL] [Abstract][Full Text] [Related]
38. Penicillin-resistant viridans group streptococci from blood cultures of infective endocarditis patients in South India.
Nandhakumar B; Senthilkumar S; Menon T; Shanmugasundaram S
Int J Antimicrob Agents; 2008 Dec; 32(6):543-4. PubMed ID: 18804349
[No Abstract] [Full Text] [Related]
39. Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients.
Shelburne SA; Lasky RE; Sahasrabhojane P; Tarrand JT; Rolston KV
Clin Infect Dis; 2014 Jul; 59(2):223-30. PubMed ID: 24755857
[TBL] [Abstract][Full Text] [Related]
40. [Post-operative bacteremia caused by multidrug-resistant Aerococcus viridans in a patient with gall bladder cancer].
Tekin Koruk S; Bayraktar M; Ozgönül A; Tümer S
Mikrobiyol Bul; 2010 Jan; 44(1):123-6. PubMed ID: 20455408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
